Redefining surgical oncology: active immune microenvironment modulation beyond tumor resection
Jiaxiong Tan1, Yan Zhang2, Jianing Wang2
1National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300000, China.
International Immunopharmacology
|March 25, 2026
Summary
Surgery can weaken the immune system, increasing cancer recurrence risk. Modifying the perioperative period can enhance antitumor immunity and improve long-term outcomes.
Area of Science:
- Oncology
- Immunology
- Surgical Science
Background:
- Surgical resection is a cornerstone of solid tumor treatment.
- Surgery induces significant changes in the tumor immune microenvironment (TME).
- Perioperative stress can suppress antitumor immunity and promote disease recurrence.
Purpose of the Study:
- To review evidence on how surgery and systemic stress impact the TME.
- To identify perioperative vulnerabilities and therapeutic targets.
- To explore strategies for optimizing surgical outcomes through immune modulation.
Main Methods:
- Comprehensive literature review of mechanistic and translational studies (PubMed, Web of Science through October 2025).
- Analysis of how surgical injury and stress responses alter immune and stromal cells.
- Identification of intraoperative and systemic interventions.
Main Results:
- Surgical stress can transiently impair anti-tumor immunity, favoring disease persistence.
- Key vulnerabilities include anesthetic choices, stress responses, and inflammatory signaling.
- Actionable entry points include localized drug delivery, immune cell reprogramming, and targeted systemic therapies.
Conclusions:
- Surgery represents a critical "immunologic window" that can be modulated.
- Perioperative interventions can potentially reduce recurrence risk and enhance long-term survival.
- Future research should focus on biomarker-driven trials and high-resolution immune monitoring.
Keywords:
Cancer surgeryImmune surveillanceIntraoperative interventionNeoadjuvant immunotherapyPerioperative immunomodulationTumor microenvironmentMore Related Videos
Related Concept Videos
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.0K
3.0K
Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K


